IP Library Granted Patent US 8,153,425
Granted Patent B2
US 8,153,425 · App. 11/918,076 · Granted Apr 10, 2012

Dendritic cell compositions and methods

Assignee: Argos Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,153,425
App. No.
11/918,076
Granted
Apr 10, 2012
Kind
B2
Abstract

Methods are provided for the production of dendritic cells from monocytes that have been incubated at a temperature of 1° C.-34° C. for a period of approximately 6 to 96 hours from the time they are isolated from a subject. After the incubation period, the monocytes can then be induced to differentiate into dendritic cells. Mature dendritic cells made by the methods of the invention have increased levels of one or more of CD80, CD83, CD86, MHC class I molecules, or MHC class II molecules as compared to mature dendritic cells prepared from monocytes that have not been held at 1° C.-34° C. for at least 6 hours from the time they were isolated from a subject. Dendritic cells made by the methods of the invention are useful for the preparation of vaccines and for the stimulation of T cells.

Claims (18)

1. A method for producing dendritic cells from monocytes, comprising:

a) providing monocytes that have been incubated without culturing at a temperature maintained between 1° C.-34° C. for a period of approximately 6 to 96 hours from the time they are isolated from a subject; and

b) inducing the differentiation of said monocytes into dendritic cells.

2. The method of claim 1 , wherein the monocytes are human monocytes.

3. The method of claim 1 , wherein the incubation temperature is maintained between 6° C.-28° C.

4. The method of claim 1 , wherein the incubation temperature is maintained between 8° C.-26° C.

5. The method of claim 1 , wherein the period of incubation is 8 to 48 hours.

6. The method of claim 5 , wherein the period of incubation is 10 to 30 hours.

7. The method of claim 1 , wherein the period of incubation is 26 to 72 hours.

8. The method of claim 1 , wherein the period of incubation is 48 to 80 hours.

9. The method of claim 1 , wherein the differentiation is induced by contacting the monocytes in a culture medium comprising an effective amount of a composition that induces the differentiation of monocytes into immature dendritic cells.

10. The method of claim 1 , wherein the monocytes are present together with peripheral blood mononuclear cells (PBMCs) during all or a portion of the incubation period.

11. The method of claim 10 , wherein the PBMCs are isolated from the subject by leukapheresis.

12. The method of claim 10 , wherein the monocytes are enriched from the PBMCs during or following the incubation period.

13. The method of claim 9 , further comprising a step of maturing the immature dendritic cells into mature dendritic cells.

14. The method of claim 13 , further comprising loading one or more antigens into said mature dendritic cells.

15. The method of claim 1 , wherein the incubation temperature is between 1° C.-20° C.

16. The method of claim 12 , further comprising the step of freezing said enriched monocytes.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2019
From: ARGOS THERAPEUTICS, INC.
To: COIMMUNE, INC.
Reel/Frame 048645/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2011
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 027385/0926 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2011
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 027005/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2011
From: KIRIN HOLDINGS KABUSHIKI KAISHA (KIRIN HOLDINGS CO., LTD.)
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 026799/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2010
From: KIRIN HOLDINGS KABUSHIKI KAISHA
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 025128/0968 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2010
From: KYOWA HAKKO KIRIN CO., LTD.
To: ARGOS THERAPEUTICS, INC.
Reel/Frame 025128/0970 →
CHANGE OF NAME Recorded Oct 11, 2010
From: KIRIN BEER KABUSHIKI KAISHA
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 025129/0185 →
CHANGE OF NAME Recorded Jun 15, 2010
From: KIRIN BEER KABUSHIKI KAISHA
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 024558/0370 →
CHANGE OF NAME Recorded Jun 15, 2010
From: KIRIN BEER KABUSHIKI KAISHA
To: KIRIN HOLDINGS KABUSHIKI KAISHA
Reel/Frame 024538/0846 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2008
From: POGUE-CALEY, REBECCA; MONESMITH, TAMARA; TCHEREPANOVA, IRINA; DINTERMAN, LOIS
To: ARGOS THERAPEUTICS, INC.; KIRIN BEER KABUSHIKI KAISHA
Reel/Frame 021818/0818 →
Continuity (1)
Related Publication 20090053251A1 · Feb 26, 2009